ANDRZEJEWSKI STEPHEN J 4
4 · KING PHARMACEUTICALS INC · Filed Mar 19, 2010
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2010-03-17+41,200→ 41,200 totalExercise: $12.44Exp: 2020-03-17→ Common Stock (41,200 underlying) - Award
Common Stock
2010-03-17+11,670→ 175,234 total
Footnotes (2)
- [F1]The reported transaction represents restricted stock that was granted on March 17, 2010, pursuant to King Pharmaceuticals, Inc. Long Term Incentive Award program. One hundred percent of such stock vests on March 17, 2013.
- [F2]Thirty-three percent of this stock option, which was granted under the King Pharmaceuticals, Inc. Long Term Incentive Award program, will vest on March 17, 2011; 33% of the stock option will vest on March 17, 2012; and the remaining 34% of the stock option will vest on March 17, 2013.